Everolimus

Everolimus (INN) (/ˌɛvəˈroʊləməs/) (earlier code name RAD001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).

It is currently used as an immunosuppressant to prevent rejection of organ transplants and treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.

单词	Everolimus
释义	Everolimus 英语百科 Everolimus Everolimus (INN) (/ˌɛvəˈroʊləməs/) (earlier code name RAD001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR). It is currently used as an immunosuppressant to prevent rejection of organ transplants and treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
随便看	T. C. R. TCR TCRA TcR alpha beta TcR alpha Gene TcR alpha Genes T.crassifolium auct.non Willd. T.craveniana S.Y.Hu tcrb TcR beta Gene TcR beta Genes TCR CD3 Complex TCR complex tcrd TcR delta Gene TcR delta Genes TCRE Tc red blood cells injection T.crenulata C.Y.Cheng et Yueh TCRF tcrg TcR gamma delta TcR gamma Gene TcR gamma Genes TcR Gene